R/R AML

Clinical trials for R/R AML explained in plain language.

Never miss a new study

Get alerted when new R/R AML trials appear

Sign up with your email to follow new studies for R/R AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Engineered immune cells take on tough leukemia in early trial

Disease control Not yet recruiting

This early-phase trial tests a new type of cell therapy called CAR-ITNK cells, designed to target two proteins (CD70 and CLL1) on leukemia cells. It will enroll 30 adults with relapsed or refractory acute myeloid leukemia (AML) who have not responded to standard treatments. Parti…

Matched conditions: R/R AML

Phase: EARLY_PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC

R/R AML

Get alerted when new R/R AML trials appear

Engineered immune cells take on tough leukemia in early trial